UPTEMPO
"UPTEMPO" is a word mark owned by Catalent Pharma Solutions, Inc., filed at the CIPO on May 8, 2023. It is registered and covers classes 1, 5, 40 and 42.
- Status
- Registered
- Since May 15, 2026
- Filed
- May 8, 2023
- Registered
- May 15, 2026
- Expires
- May 15, 2036
- Application no.
- 2256509
- Registration no.
- TMA1410893
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 4 classes
Who owns UPTEMPO
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Catalent Pharma Solutions, Inc.
United States
Representative
Gowling WLG (Canada) LLP
Gowling WLG (Canada) LLP
What the mark covers
The products and services UPTEMPO is filed for, grouped by Nice class.
Cell culture media for scientific, laboratory and medical research; Diagnostic reagents for in vitro scientific and medical research use in biochemistry, clinical chemistry and microbiology; Biological and biochemical preparations, namely, plasmids, RNA and proteins for scientific, medical research, or research use; Cell culture reagents for scientific and research use; Stem cells for research or scientific purposes; Cell growth media for growing cells for use in cell cultures for scientific use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for use in scientific research and analysis
Cell culture media for medical laboratory use; Stem cells for medical or veterinary use; Engineered proteins for use in scientific research and analysis relating to genetic diseases, gene therapy, and cell therapy; biochemicals and biologics, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, DNA plasmids, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, chimeric antigen receptor (CAR) T-cell preparations, T-cell preparations, tumor-infiltration lymphocyte (TIL) preparations, natural killer (NK) cell preparations, induced pluripotent stem cell (iPSC) preparations, mesenchymal stem cell (MSC) preparations, all for clinical use, medical use, clinical laboratory use, and medical laboratory use; Pharmaceutical preparations in the nature of viral systems, gene therapy systems, and nucleic acid delivery systems comprised of viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells used to deliver modified genetic material into other cells for medical purposes
Custom manufacture of biopharmaceuticals for use in viral vector production, and for diagnostic, medical and commercial applications in relation to cell and gene therapies
Pharmaceutical research and development; Gene therapy research; Scientific research services in the field of cell therapy; Scientific research in the field of pharmacology, pharmaceuticals, and biochemistry
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Pending
- Advertised; Vol.73 Issue 3722
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Examiner's First Report
- Search Recorded
- Pre-Assessment Letter Sent; Multiple Reasons
- Formalized
- Created
1 earlier step on the official record.
About UPTEMPO
Who owns the trademark "UPTEMPO"?
The CIPO trademark "UPTEMPO" (application 2256509) is owned by Catalent Pharma Solutions, Inc.
What is the status of "UPTEMPO"?
Its status at the CIPO is: registered.
When was "UPTEMPO" registered?
It was registered on May 15, 2026 and is due to expire on May 15, 2036.
Get this data via the API
Everything on this page comes from the Signa API. Pull UPTEMPO and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb32-333e-702e-8abf-0fde62b834dc
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb32-333e-702e-8abf-0fde62b834dc",
"object": "trademark",
"mark_text": "UPTEMPO",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "2256509",
"filing_date": "2023-05-08",
"nice_classes": [
1,
5,
40,
42
],
"owners": [
{
"name": "Catalent Pharma Solutions, Inc.",
"entity_id": "ent_019eb6fc-3d59-70de-b77a-e1780d3638e9"
}
]
}